Ida H - Search Results

1

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.

Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T. Wada M, et al. Among authors: ida h. Oncogene. 2004 Mar 25;23(13):2401-7. doi: 10.1038/sj.onc.1207395. Oncogene. 2004. PMID: 14743205

2

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y. Ito K, et al. Among authors: ida h. Cancer Res. 2005 Sep 1;65(17):7743-50. doi: 10.1158/0008-5472.CAN-05-0743. Cancer Res. 2005. PMID: 16140942

3

RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.

Yamamura Y, Lee WL, Inoue K, Ida H, Ito Y. Yamamura Y, et al. Among authors: ida h. J Biol Chem. 2006 Feb 24;281(8):5267-76. doi: 10.1074/jbc.M512151200. Epub 2005 Dec 22. J Biol Chem. 2006. PMID: 16373335 Free article.

4

The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.

Yano T, Ito K, Fukamachi H, Chi XZ, Wee HJ, Inoue K, Ida H, Bouillet P, Strasser A, Bae SC, Ito Y. Yano T, et al. Among authors: ida h. Mol Cell Biol. 2006 Jun;26(12):4474-88. doi: 10.1128/MCB.01926-05. Mol Cell Biol. 2006. PMID: 16738314 Free PMC article.

5

Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis.

Miyagawa K, Sakakura C, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Ito K, Yamagishi H, Ida H, Yazumi S, Chiba T, Ito Y, Hagiwara A. Miyagawa K, et al. Among authors: ida h. Anticancer Res. 2006 Sep-Oct;26(5B):3633-43. Anticancer Res. 2006. PMID: 17094378 Free article.

6

Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.

Tan SH, Ida H, Goh BC, Hsieh W, Loh M, Ito Y. Tan SH, et al. Among authors: ida h. Anticancer Res. 2006 Nov-Dec;26(6B):4287-92. Anticancer Res. 2006. PMID: 17201146 Free article.

7

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment.

Huang C, Ida H, Ito K, Zhang H, Ito Y. Huang C, et al. Among authors: ida h. Biochem Pharmacol. 2007 Apr 1;73(7):990-1000. doi: 10.1016/j.bcp.2006.12.013. Epub 2006 Dec 16. Biochem Pharmacol. 2007. PMID: 17276407

8

Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell line.

Hasegawa K, Yazumi S, Wada M, Sakurai T, Kida M, Yamauchi J, Hisatsune H, Tada S, Ida H, Nakase Y, Sakakura C, Hagiwara A, Chiba T. Hasegawa K, et al. Among authors: ida h. Cancer Sci. 2007 Jun;98(6):838-43. doi: 10.1111/j.1349-7006.2007.00460.x. Cancer Sci. 2007. PMID: 17470130 Free PMC article.

9

Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.

Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, Ito Y. Tan SH, et al. Among authors: ida h. Oncol Rep. 2007 Nov;18(5):1225-30. Oncol Rep. 2007. PMID: 17914577

10

Biliary complications in donors for living donor liver transplantation.

Shio S, Yazumi S, Ogawa K, Hasegawa K, Tsuji Y, Kida M, Yamauchi J, Ida H, Tada S, Uemoto S, Chiba T. Shio S, et al. Among authors: ida h. Am J Gastroenterol. 2008 Jun;103(6):1393-8. doi: 10.1111/j.1572-0241.2008.01786.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters